- Exchange: Frankfurt
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Agenus Inc+ Add to Watchlist
AJ81:GR3.256 EUR 0.251 7.16%
As of 09:59:17 ET on 03/07/2014.
Company Profile for Agenus Inc (AJ81)
Agenus, Inc. develops vaccines. The Company researches vaccines for brain cancer, kidney cancer, herpes, lung cancer, melanoma, malaria, shingles, and Alzheimer's disease.
Key Executives for Agenus Inc (AJ81)
|Garo H ArmenChairman/CEO/Co-Founder||Robert B SteinChief Scientific Officer|
|Karen H ValentineVP/Chief Compliance Ofcr/Secy||Kerry A WentworthVP:Clinical & Regulatory|
|Christine M KlaskinVP:Finance|